Jeffrey B. Mirviss, EVP&Pres, Periph Intervent at BOSTON SCIENTIFIC CORP (BSX), sold 9,871 shares at $46.35 ($459K) on 2023-02-17, disclosed to the SEC on 2023-02-21.
Seasonal sale ($459k) by EVP&Pres, Periph Intervent — this insider has traded BSX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.48 | 909 | $42K | 9.2% |
| 2 | $46.79 | 1,409 | $66K | 14.4% |
| 3 | $46.79 | 1,409 | $66K | 14.4% |
| 4 | $46.35 | 2,061 | $96K | 20.8% |
| 5 | $46.35 | 2,061 | $96K | 20.8% |
| 6 | $46.54 | 1,020 |
| $47K |
| 10.3% |
| 7 | $46.54 | 1,002 | $47K | 10.2% |
| Total | $46.53 avg | 9,871 | $459K | 100% |
| Filing → |
| BSX | SELL | 2025-02-13 | $2.7M | — | Filing → |
| BSX | SELL | 2025-01-03 | $1.3M | — | Filing → |
| BSX | SELL | 2024-05-30 | $9.6M | — | Filing → |